🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

17 results for “Peking” Clear

  1. Triptolide Wilfordii

    Peking University Third Hospital

    HIV-infection/AIDS

    phase 3 small molecule completed

    1 trial

  2. 68Ga-NY104 PET/CT

    Peking University Third Hospital

    Clear Cell Renal Cell Carcinoma

    phase 2 other active

    1 trial

  3. 68Ga-Pentixafor

    Peking University Third Hospital

    Cushing s Syndrome

    phase 2 small molecule active

    1 trial

  4. Furmonertinib

    Peking University People's Hospital

    Adenocarcinoma of Lung

    phase 2 small molecule active

    1 trial

  5. Glofitamab

    Peking University Third Hospital

    MCL

    phase 2 small molecule active

    1 trial

  6. Luveris

    Peking University Third Hospital

    Infertility

    phase 2 small molecule active

    1 trial

  7. Roxadustat

    Peking University Third Hospital

    Coronary Artery Bypass

    phase 2 small molecule terminated

    1 trial

  8. Tofacitinib

    Peking University People's Hospital

    Primary Sjögren's Syndrome

    phase 2 small molecule active

    1 trial

  9. recombinant human endostatin

    Peking University Third Hospital

    Melanoma

    phase 2 small molecule active

    1 trial

  10. Dexmedetomidine

    Peking University Third Hospital

    Breast Cancer

    approved small molecule completed

    1 trial

  11. Dexmedetomidine

    Peking University Third Hospital

    Aged

    approved small molecule completed

    1 trial

  12. ticagrelor + ASA

    Peking University Third Hospital

    Cerebrovascular Accident

    approved small molecule completed

    1 trial

  13. Combination of targeted biopsy and systematic biopsy

    Peking University Third Hospital

    Prostate Cancer

    other completed

    1 trial

  14. ERA

    Peking University Third Hospital

    Infertility, Female

    other active

    1 trial

  15. Protocol-based management of perioperative antithrombotic therapy

    Peking University Third Hospital

    Antithrombotic Therapy

    small molecule active

    1 trial

  16. chlorhexidine acetate gargle

    Peking University Third Hospital

    Esophageal Cancer

    small molecule active

    1 trial

  17. glucocorticoid plus iguratimod

    Peking University Third Hospital

    Autoimmune Diseases

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources